Related Experiment Video
Updated: Aug 8, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
An inflammatory eruption associated with recombinant human IL-6
T E Fleming1, W S Mirando, L F Soohoo
1Department of Dermatology, University Hospitals of Cleveland, Ohio 44106.
The British Journal of Dermatology
|April 1, 1994
Summary
Interleukin 6 (IL-6) therapy for breast cancer can cause skin reactions. This case report details a patient experiencing a specific cutaneous eruption following IL-6 administration during chemotherapy.
Area of Science:
- Immunology
- Oncology
- Dermatology
Background:
- Interleukin 6 (IL-6) is a cytokine involved in inflammatory responses.
- Recombinant human IL-6 is used in chemotherapy for certain cancers.
- IL-6 has demonstrated tumor regression capabilities in some malignant conditions.
Observation:
- A patient undergoing chemotherapy for breast cancer received recombinant human IL-6.
- The patient subsequently developed a distinct skin condition.
- The eruption presented as coalescent, erythematous, scaling macules and papules.
Findings:
- The cutaneous eruption appeared after the administration of recombinant human IL-6.
- This adverse dermatological event is linked to IL-6 therapy in breast cancer treatment.
- The specific presentation suggests a potential IL-6-mediated inflammatory skin response.
Implications:
- Highlights the need for monitoring dermatological side effects during IL-6 cancer therapy.
- Suggests a potential mechanism for IL-6-induced cutaneous reactions.
- Informs clinical practice regarding patient management and side effect profiling in IL-6 treated patients.
Related Concept Videos
01:30Inflammatory Response I: Vascular and Cellular
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...